NFSG
IMNM icon

Newbridge Financial Services Group’s Immunome IMNM Stock Holding History

Newbridge Financial Services Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-225
Closed -$2.41K – 1232
2023
Q4 		$2.41K Hold
225
– – ﹤0.01% 950
2023
Q3 		$1.88K Hold
225
– – ﹤0.01% 1080
2023
Q2 		$1.78K Sell
225
-150
-40% -$820 ﹤0.01% 1147
2023
Q1 		$1.87K Hold
375
– – ﹤0.01% 1200
2022
Q4 		$829 Hold
375
– – ﹤0.01% 1318
2022
Q3 		$2K Hold
375
– – ﹤0.01% 1203
2022
Q2 		$1K Hold
375
– – ﹤0.01% 1279
2022
Q1 		$2K Hold
375
– – ﹤0.01% 1292
2021
Q4 		$5K Buy
+375
New +$6.69K ﹤0.01% 1068

Other funds holding IMNM

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Newbridge Financial Services Group's IMNM Position: Q1 2024 in Review

Newbridge Financial Services Group sold out of Immunome (IMNM) in Q1 2024, closing a stake of 225 shares — an estimated $2.41K sold.

Newbridge Financial Services Group first reported a position in IMNM in Q4 2021 and held it in 9 quarters. The position peaked at $5K in Q4 2021. 104 funds tracked by Wall St. Rank hold IMNM as of Q1 2024.

  • Newbridge Financial Services Group reported no remaining Immunome position as of Q1 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 225 Immunome shares in Q1 2024, an estimated $2.41K.
  • Newbridge Financial Services Group first reported a position in Immunome in Q4 2021 and held it in 9 quarters.
  • Newbridge Financial Services Group's Immunome position peaked at $5K in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Immunome as of Q1 2024.

Based on Newbridge Financial Services Group's 13F filing for Q1 2024, filed 24 Apr 2024.